Coronavirus: CanSinoBIO’s COVID-19 vaccine 65.7 pct effective in global trial: Pakistani official
CanSino Biologics Inc’s (CanSinoBIO) COVID-19 vaccine showed 65.7 percent efficacy in preventing symptomatic cases, and a 90.98 percent success ...
Tag: CanSinoBIOs